{
    "nctId": "NCT05565534",
    "briefTitle": "Diabetes Care for Breast Cancer Patients",
    "officialTitle": "Optimizing Delivery of Diabetes Management During Breast Cancer Care",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Cancer, PreDiabetes, Type 2 Diabetes",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NON_RANDOMIZED",
    "primaryPurpose": "HEALTH_SERVICES_RESEARCH",
    "enrollmentCount": 76,
    "primaryOutcomeMeasure": "Recruitment Success Ratio",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Newly diagnosed invasive cancer\n* Plan to receive neo-adjuvant or adjuvant chemotherapy, targeted therapy, hormonal therapy, or radiation at Weill Cornell Medicine (WCM)\n\n  * Age 18+ years\n  * Pre-diabetes OR type 2 diabetes. Treatment with antidiabetic medication OR\n* HbA1c greater than or equal to 5.7 OR\n* Random glucose greater than or equal to OR\n* Fasting blood glucose greater than or equal to 100\n\nExclusion Criteria:\n\n* Patients receiving hospice care\n* Type 1 diabetes",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}